Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects
NCT01268124
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
HTC-867
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer